ARCHIVES

Low Prevalence Of Tamoxifen Use For Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 33 No. 2 | February 26, 2010

Download PDF Visit The Full Archive

Related Articles

Duke Officials Decline To Provide Details Of Probe

July 23, 2010

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

FDA Offers Grants For Conferences

May 1, 1987

By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure

July 23, 2010

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987

ACS Offers New Grants to Physicians

September 7, 1984